In Brief: Chiron Vision/Iolab consolidation
This article was originally published in The Gray Sheet
Executive Summary
Chiron Vision/Iolab consolidation: Combined company should be profitable by "third or fourth quarter this year" and should be "a substantial contributor to profitability on a margin basis by 1996" in the wake of a recent layoff of 200 employees and the closing of 5 plants, Chiron VP-corporate communications Larry Kurtz tells analysts May 17 at the Alex. Brown & Sons healthcare seminar. Chiron indicated its plans for the cuts when it acquired Iolab from Johnson & Johnson for $95 mil. in March ("The Gray Sheet" March 13, p. 15)...